TOBY (TOtal Body hYpothermia): a Study of Treatment for Perinatal Asphyxia
Launched by IMPERIAL COLLEGE LONDON · Sep 5, 2005
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
This is a multicentre prospective randomised controlled trial to determine whether a reduction of body temperature by 3-4°C following perinatal asphyxia improves survival without neurodevelopmental disability.
Full term infants will be randomised within 6 hours of birth to either a control group with the rectal temperature kept at 37 ± 0.2°C or to whole body cooling with the rectal temperature kept at 33.5 ± 0.5°C for 72 hours followed by slow rewarming.
The outcome will be assessed at 18 months of age by survival and neurological and neurodevelopmental testing.
Eligibility criteria:
Te...
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- The infant will be assessed sequentially by criteria A, B and C listed below:
- A. Infants =\>36 completed weeks gestation admitted to the Neonatal Intensive Care Unit (NICU) with at least one of the following:
- • Apgar score of =\<5 at 10 minutes after birth
- • Continued need for resuscitation, including endotracheal or mask ventilation, at 10 minutes after birth
- • Acidosis within 60 minutes of birth (defined as any occurrence of umbilical cord, arterial or capillary pH \<7.00)
- • Base Deficit =\>16 mmol/L in umbilical cord or any blood sample (arterial, venous or capillary) within 60 minutes of birth
- Infants that meet criteria A will be assessed for whether they meet the neurological abnormality entry criteria (B) by trained personnel:
- B. Moderate to severe encephalopathy, consisting of altered state of consciousness (lethargy, stupor or coma) AND at least one of the following:
- • hypotonia
- • abnormal reflexes including oculomotor or pupillary abnormalities
- • absent or weak suck
- • clinical seizures
- Infants that meet criteria A \& B will be assessed by amplitude-integrated electroencephalogram (aEEG) (read by trained personnel):
- C. At least 30 minutes duration of amplitude integrated EEG recording that shows abnormal background aEEG activity or seizures. There must be one of the following:
- • normal background with some seizure activity
- • moderately abnormal activity
- • suppressed activity
- • continuous seizure activity
- • Exclusion criteria
- • Infants expected to be \> 6 hours of age at the time of randomisation
- • Major congenital abnormalities, such as diaphragmatic hernia requiring ventilation, or congenital abnormalities suggestive of chromosomal anomaly or other syndromes that include brain dysgenesis
Trial Officials
Denis Azzopardi, MD; FRCPCH
Principal Investigator
Imperial College London
About Imperial College London
Imperial College London is a world-renowned research institution based in the United Kingdom, recognized for its commitment to advancing medical science and improving patient care through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, Imperial combines expertise across various fields, including medicine, engineering, and business, to drive breakthroughs in healthcare. The institution’s robust clinical trial programs are designed to evaluate new therapies and interventions, ensuring rigorous scientific standards and ethical practices while aiming to translate research findings into tangible benefits for patients and society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials